Anika Therapeutics, Inc. Lease Obligation Incurred
Anika Therapeutics, Inc. (ANIK) reported Lease Obligation Incurred of $220.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2021-11-05
- Anika Therapeutics, Inc. lease obligation incurred for the quarter ending 2021-09-30 was $0.00.
- Anika Therapeutics, Inc. lease obligation incurred for the quarter ending 2021-06-30 was $0.00.
- Anika Therapeutics, Inc. lease obligation incurred for the quarter ending 2021-03-31 was $220.00K.
- Anika Therapeutics, Inc. lease obligation incurred for the quarter ending 2020-09-30 was $0.00.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month |
|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $220.00K 10-Q · filed 2021-11-05 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $220.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $220.00K 10-Q · filed 2021-05-07 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |